Form 4: Prestige Consumer Healthcare Executive Exercises Options and Sells Shares

An executive at Prestige Consumer Healthcare exercised stock options and sold shares on November 12, 2024.

Summary

• Adel Mekhail, an EVP at Prestige Consumer Healthcare, exercised 5,565 stock options at a price of $44.33 per share on November 12, 2024.
• Following the exercise of options, Mr. Mekhail sold 9,063 shares of common stock at a weighted average price of $82 per share.
• The sale was executed through multiple open market transactions with prices ranging from $81.92 to $82.02.
• After these transactions, Mr. Mekhail directly owns 18,365 shares of Prestige Consumer Healthcare stock and 5,400 stock options.

Sentiment

Score: 5

Explanation: The document is a neutral report of an executive's stock transactions, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to executive stock option exercises and sales, which is common in publicly traded companies. It provides transparency into executive compensation and ownership.

Comparison to Industry Standards

• Executive stock option exercises and sales are a standard practice in publicly traded companies, and this transaction is consistent with typical insider trading activity.
• The sale price of $82 per share is a reflection of the current market value of Prestige Consumer Healthcare stock at the time of the transaction.
• The vesting schedule of the options is typical for executive compensation packages.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects a change in insider ownership.
• The sale of shares by an executive could be perceived as a neutral event by the market.

Key Dates

Keywords

stock options, insider trading, executive compensation, share sale, Prestige Consumer Healthcare, PBH, equity